Page last updated: 2024-08-17

trifluridine and Carcinoma, Non-Small Cell Lung

trifluridine has been researched along with Carcinoma, Non-Small Cell Lung in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Azijli, K; Bijnsdorp, IV; de Jong, S; Fukushima, M; Kruyt, FA; Peters, GJ; Pillai, S; Smit, J; van Roosmalen, IA	1

Other Studies

1 other study(ies) available for trifluridine and Carcinoma, Non-Small Cell Lung

Article	Year
The novel thymidylate synthase inhibitor trifluorothymidine (TFT) and TRAIL synergistically eradicate non-small cell lung cancer cells. Cancer chemotherapy and pharmacology, 2014, Volume: 73, Issue:6 Topics: Antimetabolites; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Non-Small-Cell Lung; Caspases; Cathepsin B; Cell Cycle; Cell Death; Cell Line, Tumor; Drug Synergism; Humans; Lung Neoplasms; RNA Interference; RNA, Small Interfering; Thymidylate Synthase; TNF-Related Apoptosis-Inducing Ligand; Trifluridine	2014

Article

Year

The novel thymidylate synthase inhibitor trifluorothymidine (TFT) and TRAIL synergistically eradicate non-small cell lung cancer cells.

Cancer chemotherapy and pharmacology, 2014, Volume: 73, Issue:6

Topics: Antimetabolites; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Non-Small-Cell Lung; Caspases; Cathepsin B; Cell Cycle; Cell Death; Cell Line, Tumor; Drug Synergism; Humans; Lung Neoplasms; RNA Interference; RNA, Small Interfering; Thymidylate Synthase; TNF-Related Apoptosis-Inducing Ligand; Trifluridine

2014